Symbols / SABS $3.76 -2.34% SAB Biotherapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
SABS Chart
About

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 264.24M
Enterprise Value 105.52M Income 4.26M Sales —
Book/sh 3.18 Cash/sh 1.90 Dividend Yield —
Payout 0.00% Employees 86 IPO —
P/E — Forward P/E -11.39 PEG —
P/S — P/B 1.18 P/C —
EV/EBITDA -2.30 EV/Sales — Quick Ratio 9.13
Current Ratio 9.46 Debt/Eq 3.93 LT Debt/Eq —
EPS (ttm) -0.79 EPS next Y -0.33 EPS Growth —
Revenue Growth — Earnings 2026-03-09 17:00 ROA -28.20%
ROE 14.96% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 70.28M
Shs Float 34.88M Short Float 4.06% Short Ratio 3.18
Short Interest — 52W High 6.60 52W Low 1.05
Beta 0.61 Avg Volume 596.51K Volume 186.01K
Target Price $9.50 Recom None Prev Close $3.85
Price $3.76 Change -2.34%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$9.50
Mean price target
2. Current target
$3.76
Latest analyst target
3. DCF / Fair value
$-5.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.76
Low
$6.00
High
$15.00
Mean
$9.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-11 main Chardan Capital Buy → Buy $14
2026-03-10 main HC Wainwright & Co. Buy → Buy $7
2026-01-07 init UBS — → Buy $7
2025-12-19 init Guggenheim — → Buy $15
2025-12-18 main Chardan Capital Buy → Buy $12
2025-11-17 main Chardan Capital Buy → Buy $12
2025-09-19 main Chardan Capital Buy → Buy $12
2025-09-17 init Leerink Partners — → Outperform $7
2025-08-08 main Chardan Capital Buy → Buy $12
2025-07-22 main HC Wainwright & Co. Buy → Buy $9
2025-05-15 main Chardan Capital Buy → Buy $20
2025-04-01 main Chardan Capital Buy → Buy $20
2025-04-01 reit HC Wainwright & Co. Buy → Buy $6
2025-01-29 main Chardan Capital Buy → Buy $25
2025-01-29 reit HC Wainwright & Co. Buy → Buy $6
2024-11-07 main Chardan Capital Buy → Buy $25
2024-10-09 init Craig-Hallum — → Buy $11
2024-09-12 reit Oppenheimer Outperform → Outperform $12
2024-09-09 main Chardan Capital Buy → Buy $25
2024-08-28 init Oppenheimer — → Outperform $12
News
RSS: Latest SABS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-29 SESSA CAPITAL MASTER, L.P. Beneficial Owner of more than 10% of a Class of Security — 1,740,000 $1.75 $3,045,000
2025-09-29 MOIN ANDREW D. Director — 1,740,000 $1.75 $3,045,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
48.95
+14.08%
42.91
+12.70%
38.08
+31.67%
28.92
Research And Development
34.35
+13.56%
30.25
+83.18%
16.52
-54.68%
36.44
Selling General And Administration
14.60
+4.43%
13.98
-41.25%
23.80
+45.27%
16.38
General And Administrative Expense
14.60
+4.43%
13.98
-41.25%
23.80
+45.27%
16.38
Other Gand A
14.60
+4.43%
13.98
-41.25%
23.80
+45.27%
16.38
Other Operating Expenses
—
-1.32
+40.94%
-2.24
+90.63%
-23.90
Total Expenses
48.95
+14.08%
42.91
+12.70%
38.08
+31.67%
28.92
Operating Income
-48.95
-14.08%
-42.91
-12.70%
-38.08
-31.67%
-28.92
Total Operating Income As Reported
-48.95
-14.08%
-42.91
-12.70%
-38.08
-31.67%
-28.92
EBITDA
16.60
+157.24%
-28.99
+23.97%
-38.13
-152.18%
-15.12
Normalized EBITDA
-46.16
-34.26%
-34.38
-3.21%
-33.31
-30.52%
-25.52
Reconciled Depreciation
3.08
-35.70%
4.79
+27.96%
3.75
+13.77%
3.29
EBIT
13.51
+140.00%
-33.79
+19.32%
-41.88
-127.43%
-18.41
Total Unusual Items
62.75
+1065.35%
5.39
+211.65%
-4.82
-146.38%
10.40
Total Unusual Items Excluding Goodwill
62.75
+1065.35%
5.39
+211.65%
-4.82
-146.38%
10.40
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
13.27
+138.92%
-34.11
+19.17%
-42.19
-125.14%
-18.74
Pretax Income
13.27
+138.92%
-34.11
+19.17%
-42.19
-125.45%
-18.72
Net Non Operating Interest Income Expense
1.19
+23.13%
0.97
+258.79%
0.27
+216.99%
-0.23
Interest Expense Non Operating
0.24
-24.41%
0.32
+0.99%
0.32
+4.54%
0.30
Net Interest Income
1.19
+23.13%
0.97
+258.79%
0.27
+216.99%
-0.23
Interest Expense
0.24
-24.41%
0.32
+0.99%
0.32
+4.54%
0.30
Interest Income Non Operating
1.43
+11.36%
1.29
+119.84%
0.58
+723.06%
0.07
Interest Income
1.43
+11.36%
1.29
+119.84%
0.58
+723.06%
0.07
Other Income Expense
61.04
+678.75%
7.84
+278.61%
-4.39
-142.06%
10.43
Other Non Operating Income Expenses
-1.72
-170.07%
2.45
+463.70%
0.44
+1189.00%
0.03
Gain On Sale Of Security
62.75
+1065.35%
5.39
+211.65%
-4.82
-146.38%
10.40
Tax Provision
—
—
0.00
-100.00%
0.03
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
-100.00%
2.18
Net Income Including Noncontrolling Interests
13.27
+138.92%
-34.11
+19.17%
-42.19
-125.14%
-18.74
Net Income From Continuing Operation Net Minority Interest
13.27
+138.92%
-34.11
+19.17%
-42.19
-125.14%
-18.74
Net Income From Continuing And Discontinued Operation
13.27
+138.92%
-34.11
+19.17%
-42.19
-125.14%
-18.74
Net Income Continuous Operations
13.27
+138.92%
-34.11
+19.17%
-42.19
-125.14%
-18.74
Normalized Income
-49.48
-25.30%
-39.49
-5.67%
-37.37
-38.63%
-26.96
Net Income Common Stockholders
13.27
+138.92%
-34.11
+19.17%
-42.19
-125.14%
-18.74
Diluted EPS
—
-3.68
+51.83%
-7.64
-77.26%
-4.31
Basic EPS
—
-3.68
+51.83%
-7.64
-77.26%
-4.31
Basic Average Shares
—
9.26
+67.74%
5.52
+26.86%
4.35
Diluted Average Shares
—
9.26
+67.74%
5.52
+26.86%
4.35
Diluted NI Availto Com Stockholders
-48.73
-42.87%
-34.11
+19.17%
-42.19
-125.14%
-18.74
Average Dilution Earnings
-62.00
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
172.81
+291.01%
44.20
-47.35%
83.94
+64.90%
50.90
Current Assets
101.05
+324.73%
23.79
-59.61%
58.91
+166.58%
22.10
Cash Cash Equivalents And Short Term Investments
96.59
+365.27%
20.76
-63.30%
56.57
+275.93%
15.05
Cash And Cash Equivalents
10.50
+18.03%
8.90
-84.27%
56.57
+275.93%
15.05
Other Short Term Investments
86.09
+625.72%
11.86
0.00
—
Receivables
0.95
+1622.83%
0.05
0.00
-100.00%
5.56
Accounts Receivable
—
—
0.00
-100.00%
5.56
Accrued Interest Receivable
0.95
+1622.83%
0.05
0.00
—
Prepaid Assets
—
—
—
1.49
Restricted Cash
—
—
—
0.00
Other Current Assets
3.51
+18.03%
2.98
+27.16%
2.34
+56.68%
1.49
Total Non Current Assets
71.76
+251.70%
20.40
-18.50%
25.03
-13.10%
28.81
Net PPE
19.40
-2.59%
19.92
-19.30%
24.68
-12.90%
28.34
Gross PPE
36.92
+7.03%
34.50
-0.29%
34.60
-0.06%
34.62
Accumulated Depreciation
-17.52
-20.19%
-14.57
-47.04%
-9.91
-57.87%
-6.28
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
11.66
+1.09%
11.53
+5.45%
10.94
+0.11%
10.92
Construction In Progress
0.76
0.00
0.00
-100.00%
0.31
Other Properties
17.44
+9.70%
15.90
+10.68%
14.36
+1.94%
14.09
Leases
7.06
+0.00%
7.06
-24.01%
9.30
+0.00%
9.30
Investments And Advances
46.89
0.00
—
—
Non Current Deferred Assets
0.15
-42.50%
0.26
0.00
—
Non Current Prepaid Assets
5.31
+2302.45%
0.22
-36.90%
0.35
-25.12%
0.47
Total Liabilities Net Minority Interest
21.32
+16.95%
18.23
-31.59%
26.64
+34.24%
19.85
Current Liabilities
10.68
+33.86%
7.98
-26.21%
10.81
-27.88%
14.99
Payables And Accrued Expenses
9.73
+35.74%
7.17
-6.16%
7.64
-37.06%
12.13
Payables
3.15
+44.70%
2.17
-9.68%
2.41
-72.14%
8.64
Accounts Payable
3.15
+85.62%
1.69
+79.16%
0.95
-74.29%
3.68
Other Payable
—
0.48
-67.20%
1.46
-70.24%
4.91
Current Accrued Expenses
6.58
+31.84%
4.99
-4.54%
5.23
+49.66%
3.50
Pensionand Other Post Retirement Benefit Plans Current
—
—
2.99
+104.31%
1.46
Total Tax Payable
—
—
0.04
-20.00%
0.05
Current Debt And Capital Lease Obligation
0.95
+17.19%
0.81
-56.18%
1.85
+32.70%
1.40
Current Debt
—
0.28
-73.75%
1.05
+36.00%
0.77
Other Current Borrowings
—
—
—
—
Current Capital Lease Obligation
0.95
+77.50%
0.54
-33.16%
0.80
+28.60%
0.62
Current Deferred Liabilities
—
0.00
-100.00%
1.32
0.00
Current Deferred Revenue
—
0.00
-100.00%
1.32
0.00
Other Current Liabilities
—
—
—
—
Total Non Current Liabilities Net Minority Interest
10.63
+3.79%
10.25
-35.27%
15.83
+226.13%
4.85
Long Term Debt And Capital Lease Obligation
5.00
+29.61%
3.86
-4.86%
4.05
-10.55%
4.53
Long Term Debt
—
—
—
0.54
Long Term Capital Lease Obligation
5.00
+29.61%
3.86
-4.86%
4.05
+1.59%
3.99
Stockholders Equity
151.49
+483.35%
25.97
-54.68%
57.30
+84.49%
31.06
Common Stock Equity
151.49
+483.35%
25.97
-54.68%
57.30
+84.49%
31.06
Capital Stock
0.00
+414.15%
0.00
+0.64%
0.00
+83.14%
0.00
Common Stock
0.00
+409.73%
0.00
+0.65%
0.00
+82.16%
0.00
Preferred Stock
0.00
+1240.00%
0.00
+0.00%
0.00
0.00
Share Issued
47.66
+410.13%
9.34
+0.68%
9.28
+82.17%
5.09
Ordinary Shares Number
47.61
+412.55%
9.29
+0.69%
9.23
+83.07%
5.04
Treasury Shares Number
0.05
+0.00%
0.05
+0.00%
0.05
+0.00%
0.05
Additional Paid In Capital
267.72
+71.84%
155.79
+1.92%
152.86
+81.01%
84.45
Retained Earnings
-110.90
+10.69%
-124.17
-37.87%
-90.06
-88.14%
-47.87
Gains Losses Not Affecting Retained Earnings
0.19
+237.74%
-0.14
-612.53%
0.03
0.00
Treasury Stock
5.52
+0.00%
5.52
+0.00%
5.52
+0.00%
5.52
Other Equity Adjustments
0.19
+237.74%
-0.14
-612.53%
0.03
—
Total Equity Gross Minority Interest
151.49
+483.35%
25.97
-54.68%
57.30
+84.49%
31.06
Total Capitalization
151.49
+483.35%
25.97
-54.68%
57.30
+81.33%
31.60
Working Capital
90.37
+471.51%
15.81
-67.12%
48.09
+576.98%
7.10
Invested Capital
151.49
+477.22%
26.25
-55.02%
58.35
+80.25%
32.37
Total Debt
5.95
+27.45%
4.67
-20.96%
5.91
-0.37%
5.93
Capital Lease Obligations
5.95
+35.46%
4.39
-9.54%
4.86
+5.24%
4.61
Net Tangible Assets
151.49
+483.35%
25.97
-54.68%
57.30
+84.49%
31.06
Tangible Book Value
151.49
+483.35%
25.97
-54.68%
57.30
+84.49%
31.06
Available For Sale Securities
46.89
—
—
—
Current Notes Payable
0.00
-100.00%
0.28
-73.75%
1.05
+36.00%
0.77
Derivative Product Liabilities
5.64
-11.80%
6.39
-45.74%
11.77
+3568.79%
0.32
Dueto Related Parties Current
—
—
—
0.00
Interest Payable
0.02
-6.10%
0.02
-71.23%
0.08
+852.09%
0.01
Investmentin Financial Assets
46.89
0.00
—
—
Preferred Stock Equity
0.00
+1240.00%
0.00
+0.00%
0.00
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-44.78
-30.57%
-34.29
-36.52%
-25.12
-7.08%
-23.46
Cash Flow From Continuing Operating Activities
-44.78
-30.57%
-34.29
-36.52%
-25.12
-7.08%
-23.46
Net Income From Continuing Operations
13.27
+138.92%
-34.11
+19.17%
-42.19
-125.14%
-18.74
Depreciation Amortization Depletion
3.08
-35.70%
4.79
+27.96%
3.75
+13.77%
3.29
Depreciation
3.08
-35.70%
4.79
+27.96%
3.75
+13.77%
3.29
Depreciation And Amortization
3.08
-35.70%
4.79
+27.96%
3.75
+13.77%
3.29
Other Non Cash Items
0.17
+172.75%
-0.24
-106.39%
3.71
+11623.32%
-0.03
Stock Based Compensation
5.21
+77.12%
2.94
+21.38%
2.42
-9.37%
2.67
Operating Gains Losses
-62.83
-1066.72%
-5.39
-210.63%
4.87
+146.74%
-10.42
Gain Loss On Investment Securities
-62.83
-1066.72%
-5.39
-211.65%
4.82
+146.38%
-10.40
Gain Loss On Sale Of PPE
—
0.00
-100.00%
0.04
+381.51%
-0.02
Change In Working Capital
-3.69
-60.30%
-2.30
-198.83%
2.33
+1079.15%
-0.24
Change In Receivables
-0.89
-1522.83%
-0.05
-100.99%
5.56
+126.42%
2.45
Changes In Account Receivables
—
0.00
-100.00%
5.56
+126.42%
2.45
Change In Prepaid Assets
-5.29
-795.11%
-0.59
-12.77%
-0.52
-177.62%
0.67
Change In Payables And Accrued Expense
2.42
+887.87%
-0.31
+93.03%
-4.42
-33.04%
-3.32
Change In Accrued Expense
0.94
+176.48%
-1.23
+28.21%
-1.71
+32.43%
-2.54
Change In Payable
1.48
+60.59%
0.92
+134.18%
-2.70
-245.58%
-0.78
Change In Account Payable
1.48
+60.59%
0.92
+134.18%
-2.70
-246.63%
-0.78
Change In Other Working Capital
0.07
+105.01%
-1.35
-178.72%
1.71
+1809.71%
-0.10
Change In Other Current Assets
—
—
0.39
+624.72%
0.05
Investing Cash Flow
-121.71
-917.42%
-11.96
-7733.63%
-0.15
+92.69%
-2.09
Cash Flow From Continuing Investing Activities
-121.71
-917.42%
-11.96
-7733.63%
-0.15
+92.69%
-2.09
Net PPE Purchase And Sale
-0.93
-176.54%
-0.34
-120.86%
-0.15
+92.69%
-2.09
Purchase Of PPE
-0.93
-176.69%
-0.34
-71.07%
-0.20
+90.90%
-2.17
Sale Of PPE
0.00
0.00
-100.00%
0.04
-41.81%
0.08
Capital Expenditure
-0.93
-176.69%
-0.34
-71.07%
-0.20
+90.90%
-2.17
Net Investment Purchase And Sale
-120.77
-938.91%
-11.63
0.00
—
Purchase Of Investment
-142.04
-279.31%
-37.45
0.00
—
Sale Of Investment
21.26
-17.66%
25.82
0.00
—
Financing Cash Flow
168.30
+14452.36%
-1.17
-101.76%
66.77
+6250.81%
1.05
Cash Flow From Continuing Financing Activities
168.30
+14452.36%
-1.17
-101.76%
66.77
+6250.81%
1.05
Net Issuance Payments Of Debt
-0.42
+53.87%
-0.91
-132.30%
-0.39
+67.05%
-1.19
Issuance Of Debt
0.00
-100.00%
0.52
-32.57%
0.77
-38.10%
1.24
Repayment Of Debt
-0.42
+70.60%
-1.42
-23.13%
-1.16
+52.27%
-2.42
Long Term Debt Issuance
0.00
-100.00%
0.52
-32.57%
0.77
-38.10%
1.24
Long Term Debt Payments
-0.14
-8.00%
-0.13
+88.58%
-1.16
+52.27%
-2.42
Net Long Term Debt Issuance
-0.14
-137.13%
0.38
+198.34%
-0.39
+67.05%
-1.19
Short Term Debt Payments
-0.28
+78.63%
-1.29
—
—
Net Short Term Debt Issuance
-0.28
+78.63%
-1.29
—
—
Net Common Stock Issuance
168.73
0.00
0.00
-100.00%
2.16
Common Stock Payments
—
—
0.00
+100.00%
-5.52
Repurchase Of Capital Stock
—
—
0.00
+100.00%
-5.52
Proceeds From Stock Option Exercised
0.00
-100.00%
0.02
-99.97%
59.66
+77414.37%
0.08
Net Other Financing Charges
-0.01
+95.82%
-0.29
—
34.34
Changes In Cash
1.82
+103.83%
-47.43
-214.28%
41.50
+269.40%
-24.50
Effect Of Exchange Rate Changes
-0.21
+11.48%
-0.24
-1429.35%
0.02
0.00
Beginning Cash Position
8.90
-84.27%
56.57
+275.93%
15.05
-61.95%
39.55
End Cash Position
10.50
+18.03%
8.90
-84.27%
56.57
+275.93%
15.05
Free Cash Flow
-45.71
-31.99%
-34.63
-36.79%
-25.32
+1.21%
-25.63
Interest Paid Supplemental Data
0.24
-35.28%
0.37
+52.34%
0.25
-16.33%
0.29
Common Stock Issuance
168.73
0.00
0.00
-100.00%
7.68
Issuance Of Capital Stock
168.73
0.00
-100.00%
7.50
-2.35%
7.68
Net Preferred Stock Issuance
—
0.00
-100.00%
7.50
0.00
Preferred Stock Issuance
—
0.00
-100.00%
7.50
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category